BIT’s 17th Annual International Congress of
Drug Discovery Science & Technology 2019
Theme: The Disruptive, Integrate, Innovation and Development
Time: November 15-17, 2019
Place: Nanjing, China |
Important Activities |
Scientific Program |
|||||||||
Scientific Program |
||
Stream 9 Target Kingdom |
||
Stream 901: Novel Therapeutic Targets |
||
Chair: Dr. Xiaoyan Jiang, Professor, University of British Columbia, Canada | ||
Co-chair: Dr. Bing Li, Associate Professor, University of Louisville, USA |
||
Time |
Face On |
Speeches and Speakers |
08:30-08:35 |
Chair's Introduction |
|
08:35-08:55 |
|
Title: Transport Mechanism and Inhibition of ABC Efflux Transporters |
08:55-09:15 |
|
Title: A Novel Treatment Approach to Selectively Target Drug-resistant Cancer Stem Cells |
09:15-09:35 |
|
Title: Identifying Circulating A-FABP as a New Linker for Obesity-associated Breast Cancer |
09:35-09:55 |
|
Title: Carcinoma Associated Fibroblasts Exosomes Promote Breast Cancer Stem Cell Properties Via miRNAs |
09:55-10:15 | ![]() |
Title: Folate receptor-targeted RNAi Nanoparticles for silencing STAT3 in Tumor-associated Macrophages and Tumor Cells Dr. Yue Tang, Associate Professor, China Pharmaceutical University, China |
Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China
Tel: 0086-411-84799609, Fax: 0086-411-84796897
Copyright © 2003-2019 BIT Group Global Ltd.